Mesenchymal stem cells in breast cancer therapy: Mechanisms, applications, and clinical prospects
Ayush Journal of Integrative Oncology · 2026-04 · 3 (2) · 55-70
DOI: 10.4103/ajio.ajio_9_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ayush Journal of Integrative Oncology, online erschienen am 14.07.2026. Verfasst von Sumairah Qadir und 2 weiteren Autor:innen. Die Arbeit nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Breast cancer remains a serious worldwide health issue with intense biological heterogeneity, disparate clinical patterns, and long-lasting difficulties of metastasis and resistance to therapeutic treatments in spite of extensive advances in diagnostic and therapeutic tools. Limitations of the traditional regimens, such as systemic toxicity, rise of drug resistance, and limited ability of more specific methods of therapy, have forced the search for new, personalized approaches to treatment. Mesenchymal stem cell (MSCs) have emerged as interesting prospects in breast cancer therapy due to their tumor-homing properties, immunomodulatory qualities, and ability to deliver drugs to cells. This review is a critical interrogation of the biology of MSCs, including their origin, phenotypic changes, migration patterns, as well as their immunoregulatory processes in oncological settings. It also unravels the complex interaction between MSCs and the breast cancer microenvironment, which reveals their dualistic roles of tumor-promoters and tumor-suppressors through paracrine signaling, direct cell–cell contact, and MSC-derived exosomes. Especially, the particular focus is given to epithelial–mesenchymal transition, metastatic dissemination, and immune modulation. The review concludes by considering safety issues, such as the possibility of tumor support and malignant transformation, hence supporting the need to carefully regulate and carefully engineer MSC-based interventions. This is a synopsis of all of these to present a complete picture of the therapeutic potential, current challenges, and future translational directions of MSC-based paradigms in the management of breast cancer.
Zitieren
APA
Qadir, S., Chandel, P., & Rather, M. A. (2026). Mesenchymal stem cells in breast cancer therapy: Mechanisms, applications, and clinical prospects. Ayush Journal of Integrative Oncology, 3(2), 55-70. https://doi.org/10.4103/ajio.ajio_9_26
Vancouver
Qadir S, Chandel P, Rather MA. Mesenchymal stem cells in breast cancer therapy: Mechanisms, applications, and clinical prospects. Ayush Journal of Integrative Oncology. 2026;3(2):55-70. doi:10.4103/ajio.ajio_9_26
BibTeX
@article{Qadir2026,
author = {Qadir, Sumairah and Chandel, Pallavi and Rather, Mohammad Anees},
title = {Mesenchymal stem cells in breast cancer therapy: Mechanisms, applications, and clinical prospects},
journal = {Ayush Journal of Integrative Oncology},
year = {2026},
volume = {3},
number = {2},
pages = {55--70},
doi = {10.4103/ajio.ajio_9_26}
}
EUVIMED